Ofatumumab is an anti-CD20 antibody used in the treatment of chronic lymphocytic leukemia (CLL) for patients with particular treatment histories and specific responsiveness to anticancer therapies. The DrugMonitor™ Anti-Ofatumumab Antibody (VS-1224-YC836) is an anti-drug antibody (ADA) against Ofatumumab. This drug-based antibody is raised in mice immunized with the Ofatumumab. The anti-Ofatumumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Ofatumumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-MS4A1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-028)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human CD20. It is a human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation.
There are currently no Customer reviews or questions for VS-1224-YC836. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.